Fukushima Tamio, Hamada Yoshimasa, Komiyama Masatoshi, Matsuno Yoshiharu, Mori Chisato, Horii Ikuo
Drug Safety Research and Development, Nagoya Laboratories, Pfizer Japan Inc., 5-2 Taketoyo, Aichi 470-2393, Japan.
Reprod Toxicol. 2007 Feb;23(2):153-7. doi: 10.1016/j.reprotox.2006.10.003. Epub 2006 Oct 28.
Previously, we reported that decreased epididymal expression of CD59 and decay accelerating factor (DAF) genes may affect sperm motility and the acrosome reaction in rats treated long-term (28 days) with sulfasalazine. To investigate the early effects of sulfasalazine on the male reproductive tract, we presently examined sperm motility, the acrosome reaction, and gene expression in the testes and epididymides of rats treated with sulfasalazine for 1, 7 or 14 days. Reduced sperm motility and acrosome reactions were noted on day 7, however, there were no remarkable changes in testicular gene expression. On the other hand, attenuated epididymal gene expression of CD59 and DAF was observed as early as day 1. As CD59 and DAF are secreted from the epididymis and play a role in sperm maturation, we hypothesize that sulfasalazine affects sperm maturation as an early effect and that CD59 and DAF genes are related to the negative effect.
此前,我们报道过,长期(28天)服用柳氮磺胺吡啶的大鼠,附睾中CD59和衰变加速因子(DAF)基因的表达降低,可能会影响精子活力和顶体反应。为了研究柳氮磺胺吡啶对雄性生殖道的早期影响,我们目前检测了用柳氮磺胺吡啶处理1、7或14天的大鼠的精子活力、顶体反应以及睾丸和附睾中的基因表达。在第7天观察到精子活力和顶体反应降低,然而,睾丸基因表达没有显著变化。另一方面,早在第1天就观察到附睾中CD59和DAF基因表达减弱。由于CD59和DAF是从附睾分泌的,并且在精子成熟过程中发挥作用,我们推测柳氮磺胺吡啶作为早期效应会影响精子成熟,并且CD59和DAF基因与这种负面影响有关。